Literature DB >> 3010598

Induction of thymidine kinase activity by viruses with group B DNA genomes: bovine cytomegalovirus (bovine herpesvirus 4).

S Kit, M Kit, H Ichimura, R Crandell, S McConnell.   

Abstract

The bovine herpesvirus type 4 (BHV-4) group has a slow replication cycle, a narrow host range, and cytopathogenic effects characteristic of cytomegaloviruses (CMV), but a Group B genome structure similar to that of lymphotropic Herpesvirus saimiri (HVS). Reference BHV-4 strain DN599 and BHV-4 strains N124 and FHV-2 induced in the cytosol fraction of thymidine kinase-negative (TK-) rabbit skin (RAB-BU) cell mutants a novel TK activity. The BHV-4-induced thymidine kinase (TK) differed from the principal cytosol TK of mock-infected cells in PAGE mobility (Rm) under non-denaturing conditions and in the capacity to efficiently substitute CTP for ATP as a phosphate donor. The BHV-4 thymidine phosphorylating activity could also be distinguished from many common herpesvirus-induced TKs because it lacked iododeoxycytidine phosphorylating activity. Iododeoxyuridine, trifluorothymidine and bromovinyldeoxyuridine inhibited [3H]thymidine (0.01 mM) phosphorylation by the BHV-4 enzyme in a dose-dependent manner, but arabinosylthymine and 2'-fluoro-5-methyl-arabinosyluracil (FMAU) were poor inhibitors of [3H]thymidine phosphorylation, and acyclovir and (dihydroxy-2-propoxymethyl)guanine (DHPG) did not inhibit at all at 60 and 40 times the concentrations of [3H]thymidine, respectively.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010598     DOI: 10.1016/0168-1702(86)90041-9

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  15 in total

1.  Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir.

Authors:  E A Gustafson; R F Schinazi; J D Fingeroth
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

3.  Studies of in vivo distribution of bovine herpesvirus type 4 in the natural host.

Authors:  L Egyed; A Ballagi-Pordány; A Bartha; S Belák
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Genome sequence of bovine herpesvirus 4, a bovine Rhadinovirus, and identification of an origin of DNA replication.

Authors:  W Zimmermann; H Broll; B Ehlers; H J Buhk; A Rosenthal; M Goltz
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Glycoprotein B of bovine herpesvirus type 4: its phylogenetic relationship to gB equivalents of the herpesviruses.

Authors:  M Goltz; H Broll; A Mankertz; W Weigelt; H Ludwig; H J Buhk; K Borchers
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

6.  Genomic diversity among bovine herpesvirus 4 field isolates.

Authors:  M Bublot; G Wellemans; M F Van Bressem; J Dubuisson; P P Pastoret; E Thiry
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Location and characterization of the bovine herpesvirus type 4 thymidine kinase gene; comparison with thymidine kinase genes of other herpesviruses.

Authors:  P Lomonte; M Bublot; P P Pastoret; E Thiry
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  Comparative study on the in vitro replication and genomic variability of Argentinean field isolates of bovine herpesvirus type 4 (BoHV-4).

Authors:  A E Verna; S E Pérez; J M Manrique; M R Leunda; A C Odeón; L R Jones
Journal:  Virus Genes       Date:  2016-03-19       Impact factor: 2.332

9.  Analysis of bovine herpesvirus 4 (DN 599) major antigens with monoclonal antibodies and polyclonal immune serum.

Authors:  H Li; D T Shen; D Burger; W C Davis; J R Gorham
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  Investigation of the susceptibility of human cell lines to bovine herpesvirus 4 infection: demonstration that human cells can support a nonpermissive persistent infection which protects them against tumor necrosis factor alpha-induced apoptosis.

Authors:  L Gillet; F Minner; B Detry; F Farnir; L Willems; M Lambot; E Thiry; P-P Pastoret; F Schynts; A Vanderplasschen
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.